<a href="https://laohu8.com/S/FOXO">FOXO Technologies Inc.</a> Announces Agreement to Acquire Vector Biosource Inc. in Strategic Expansion Move
FOXO Technologies Inc. announced its agreement to acquire Vector Biosource Inc., a company specializing in information, data, and biospecimen sourcing for the biotechnology, clinical research, and pharmaceutical industries. The acquisition involves a purchase price comprising $500,000 in cash, 60,000 shares of Series E Cumulative Redeemable Secured Preferred Stock valued at $1.5 million, and warrants to buy $2 million of FOXO's common stock. An additional 80,000 Series E Preferred Stock shares, valued at up to $2 million, may be issued based on future revenue and cash collection milestones. FOXO plans to support Vector's growth initiatives with up to $1.2 million in funding. The acquisition is expected to close following the satisfaction of closing conditions.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. FOXO Technologies Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-25-013398), on September 15, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.